Skip to main content
Home
Zeitschriften
Zeitungen
Podcast
Gesundheitspolitik
Praxis
Allerlei
Jobs
Fachgebiete
Allgemeinmedizin Anästhesiologie & Intensivmedizin Apotheke Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kinder & Jugendheilkunde Neurologie & Psychiatrie Orthopädie & Unfallchirurgie Pflege Urologie Zahnmedizin
Subfächer Innere Medizin
Diabetologie Gastroenterologie Infektiologie Kardiologie Onkologie und Hämatologie Pneumologie Rheumatologie
Fortbildungen
Überblick Fortbildungen DFP-Literaturstudium-Artikel DFP-Webcast Fortbildungen DFP-Podcasts
Erweiterte Suche
Anmelden
nach oben
hautnah
Literatur
  1. Gilchrest BA (2011) Molecular aspects of tanning. J Invest Dermatol 131(E1):E14–E17PubMedView Article
  2. Böhm M, Luger TA (2010) α-Melanozyten-stimulierendes Hormon. Hautarzt 61:497–504PubMedView Article
  3. Ke MS et al (2006) Optimal treatments for hyperpigmentation. 9. J Cosmet Laser Ther 8:7–13PubMedView Article
  4. Lacz NL et al (2004) Postinflammatory hyperpigmentation: a common but troubling condition. Int J Dermatol 43:362–365PubMedView Article
  5. Kang HY et al (2011) Transcriptional profiling shows altered expression of wnt pathway- and lipid metabolism-related genes as well as melanogenesis-related genes in melasma. J Invest Dermatol 131:1692–1700PubMedView Article
  6. Fistarol SK, Itin PH (2010) Disorders of pigmentation. J Dtsch Dermatol Ges 8:187–201PubMedView Article
  7. Rigopoulos D et al (2007) Hyperpigmentation and melasma. J Cosmet Dermatol 6:195–202PubMedView Article
  8. Ramirez CO (1957) Los cenicientos: problema clinico. In: Report of the first central American Congress of Dermatology, San Salvador, December 5–8. Publisher, San Salvador, S 122–130
  9. Fernandez-Flores A, Montero MG (2006) Ashy dermatosis, or „Tyndall-effect“ dermatosis. Dermatol Online J 12:14PubMed
  10. Ono S et al (2012) Ashy dermatosis with prior pruritic and scaling skin lesions. J Dermatol (Epub ahead of print)
  11. Vega-Memije ME, Domínguez-Soto L (2010) Ashy dermatosis. Int J Dermatol 49:228–229PubMedView Article
  12. Schwartz RA (2004) Erythema dyschromicum perstans: the continuing enigma of Cinderella or ashy dermatosis. Int J Dermatol 43:230–232PubMedView Article
  13. Vásquez-Ochoa LA et al (2006) Immunopathologic study of erythema dyschromicum perstans (ashy dermatosis). Int J Dermatol 45:937–941PubMedView Article
  14. Zaynoun S et al (2008) Ashy dermatoses – a critical review of the literature and a proposed simplified clinical classification. Int J Dermatol 47:542–544PubMedView Article
  15. Halder RM, Richards GM (2004) Topical agents used in the management of hyperpigmentation. Skin Therapy Lett 9:1–3PubMed
  16. Grimes P, Callender V (2006) Tazarotene cream for postinflammatory hyperpigmentation and acne vulgaris in darker skin: a double-blind, randomized, vehicle-controlled study. Cutis 77:45–50PubMed
  17. Ho SG et al (2011) A retrospective analysis of the management of acne post-inflammatory hyperpigmentation using topical treatment, laser treatment, or combination topical and laser treatments in oriental patients. Lasers Surg Med 43:1–7PubMedView Article
Metadaten
Titel
Sekundäre Hyperpigmentierungen
Krankheitsbild mit breitem Spektrum
verfasst von
Prof. Dr. W. Krause
Publikationsdatum
01.05.2013
Verlag
Springer Vienna
Erschienen in
hautnah / Ausgabe 2/2013
Print ISSN: 1866-2250
Elektronische ISSN: 2192-6484
DOI
https://doi.org/10.1007/s12326-013-0054-4

Weitere Artikel der Ausgabe 2/2013